Remedee Labs

Remedee Labs

Grenoble, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Remedee Labs is a commercial-stage medical device and digital health company pioneering a novel, non-pharmaceutical approach to chronic pain. Its flagship products, Novi Rem™ for osteoarthritis pain and Fibro Rem™ for fibromyalgia, combine a proprietary millimeter wave neuromodulation wristband that stimulates the body's endorphin release with a holistic digital care platform. The company has achieved significant regulatory milestones, including the first CE mark in Europe for a medical device to treat fibromyalgia, and is backed by clinical data demonstrating improvements in pain, sleep, fatigue, and quality of life. Currently, its solutions are available only in France.

Chronic PainFibromyalgiaOsteoarthritis

Technology Platform

Non-invasive millimeter wave (MMW) neuromodulation technology designed to stimulate peripheral nerves to trigger endogenous endorphin release, integrated with a digital services platform for remote monitoring, personalized coaching, and multidisciplinary care support.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The global shift towards non-opioid, drug-free pain management creates a massive market opportunity.
The company's first-mover advantage with a CE-marked device for fibromyalgia provides a strong foothold in a high-need area with limited competition from approved medical devices.
The integrated digital platform allows for scalable, personalized care and continuous real-world data collection to strengthen value propositions to payers.

Risk Factors

Securing reimbursement outside of France is a major hurdle for adoption and scaling.
The company faces competition from both established pharmaceutical interventions and a growing array of digital health and neuromodulation devices.
Successful execution requires simultaneously scaling hardware logistics, software platforms, and human-supported care services across diverse markets.

Competitive Landscape

Remedee competes in the non-pharmacological chronic pain management space, which includes wearable neuromodulation devices (e.g., TENS units, vagus nerve stimulators), prescription digital therapeutics for pain (e.g., cognitive behavioral therapy apps), and other complementary therapies. Its key differentiator is the specific millimeter-wave technology for endorphin stimulation combined with a holistic care platform, setting it apart from simpler, single-modality competitors.